Tolerance and Efficacy Open-label Study With RV4421B, in Various Populations With Atopic Dermatitis for 12 Weeks | MicrobiomeTrials← Back to trialsNCT07014007
Tolerance and Efficacy Open-label Study With RV4421B, in Various Populations With Atopic Dermatitis for 12 Weeks
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2025-09-30Est. Completion: 2026-11
Enrollment target: 105 participants Locations- Insight Research Ltd, Quatre Bornes, Mauritius, Mauritius
Other microbiome trials you might be interested in
Chronic Hand Eczema
The design is a prospective, observational registry for subjects with CHE under the care of dermatology or other qualifi…
Multiple LocationsEst. completion Dec 31, 2099
EczemaDermatitisSkin Diseases, GeneticDermatitis, AtopicSkin Diseases
Background:
\- Atopic dermatitis, or eczema, is a chronic skin disorder. Patients sometimes have infections with S. aur…
Bethesda, United StatesEst. completion Jan 1, 2027
Atopic Dermatitis (Eczema)Psoriasis
The goal of this clinical trial is to demonstrate the feasibility of a trial that examines the impact of changes in diet…
San Francisco, United StatesEst. completion Mar 17, 2028